• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB STELLARIS ELITE VISION ENHANCEMENT SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB STELLARIS ELITE VISION ENHANCEMENT SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number BL15455
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Eye Injury (1845); Inflammation (1932); Vitrectomy (2643)
Event Date 07/28/2020
Event Type  Injury  
Manufacturer Narrative
The root cause of the event is unknown has the user facility as eliminated the stellaris system as a potential source of contamination.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.No further investigation or corrective action is necessary.
 
Event Description
The user facility in france reported a patient experienced toxic anterior segment syndrome (tass), the same day after having anterior surgery with a diagnostic vitrectomy and anterior chamber puncture, involving the stellaris elite pc.The healthcare facility eliminated the stellaris system as a potential cause of the event after a bausch & lomb sales representative explained the mechanisms of the system.Visual acuity as of (b)(6) 2020 was 1/10.The patient presented with good evolution and left the hospital.Initially thought to be endophthalmitis, bacteriological testing performed was negative.
 
Manufacturer Narrative
Additional information received, the patient had gradual decrease in inflammation and corneal edema.Patient's visual acuity one month post procedure 5/10 p2, persistence of minimal corneal edema.No tyndall or hyalitis.Anti-inflammatory treatment was decreased.The investigation is complete.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLARIS ELITE VISION ENHANCEMENT SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
BAUSCH + LOMB
rochester NY 14609
MDR Report Key10477157
MDR Text Key205342859
Report Number0001920664-2020-00100
Device Sequence Number1
Product Code HQC
Combination Product (y/n)Y
PMA/PMN Number
K170052
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup
Report Date 01/01/2005,08/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBL15455
Device Catalogue NumberBL15455
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 08/03/2020
Initial Date FDA Received09/01/2020
Supplement Dates Manufacturer Received09/03/2020
Supplement Dates FDA Received09/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BL5115-3 LOT W5075, ALCON BSS,PHACO PACK AND KNIFE
Patient Outcome(s) Required Intervention;
-
-